The challenge of creating evidence-based clinical practice guidelines for the use of hyperthermic intraperitoneal chemotherapy in the management of peritoneal malignancies
- PMID: 32669920
- PMCID: PMC7339849
- DOI: 10.3747/co.27.6679
The challenge of creating evidence-based clinical practice guidelines for the use of hyperthermic intraperitoneal chemotherapy in the management of peritoneal malignancies
Conflict of interest statement
CONFLICT OF INTEREST DISCLOSURES We have read and understood Current Oncology’s policy on disclosing conflicts of interest, and we declare that we have none.
Comment on
-
Indications for hyperthermic intraperitoneal chemotherapy with cytoreductive surgery: a clinical practice guideline.Curr Oncol. 2020 Jun;27(3):146-154. doi: 10.3747/co.27.6033. Epub 2020 Jun 1. Curr Oncol. 2020. PMID: 32669924 Free PMC article.
References
-
- Verwaal VJ, van Ruth S, de Bree E, et al. Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer. J Clin Oncol. 2003;21:3737–43. doi: 10.1200/JCO.2003.04.187. - DOI - PubMed
-
- Quenet F, Elias D, Roce L, et al. A unicancer phase iii trial of hyperthermic intra-peritoneal chemotherapy (hipec) for colorectal peritoneal carcinomatosis (pc): prodige 7 [abstract LBA3503] J Clin Oncol. 2018;36 doi: 10.1200/JCO.2018.36.18_suppl.LBA3503. [Available online at: https://ascopubs.org/doi/abs/10.1200/JCO.2018.36.18_suppl.LBA3503; cited 6 June 2020] - DOI - DOI
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical